Tofatake 5 Tablet contains Tofacitinib, an oral Janus kinase (JAK) inhibitor used in the treatment of autoimmune conditions. By selectively targeting and inhibiting specific enzymes (JAK1, JAK2, JAK3), Tofacitinib helps regulate immune system activity. This mechanism is vital in reducing inflammation caused by overactive immune responses in conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofacitinib works by blocking signals from cytokines, which are proteins involved in the inflammatory process, thereby preventing the damaging effects of inflammation on joints and tissues. This leads to a reduction in symptoms such as joint pain, swelling, and stiffness in rheumatoid arthritis and psoriatic arthritis, as well as helping control inflammation in the gastrointestinal tract in ulcerative colitis.
Tofatake 5 Tablet is typically prescribed to individuals who have not responded well to other treatments or have contraindications to alternative therapies. The medication helps improve both the physical symptoms and quality of life by managing inflammation and reducing disease activity.
This drug should be taken exactly as prescribed by your healthcare provider, with or without food. Regular monitoring is required to assess potential side effects, such as effects on blood cell counts or liver function.